Corvinus University of Budapest, Health Economics and Health Technology Assessment Research Centre, Budapest, Hungary.
J Nutr Health Aging. 2010 Oct;14(8):633-9. doi: 10.1007/s12603-010-0309-1.
The main aim of this paper is to give an overview on the quality of life, health care utilisation and costs of dementia in Hungary.
A cross-sectional non-population based study of 88 consecutive dementia patients and their caregivers was conducted in three GP practices and one outpatient setting in 2008. Resource Utilization in Dementia (RUD), Mini Mental State Examination (MMSE) and quality of life (EQ-5D) were surveyed and cost calculations were performed. Costs of patients living at home were estimated by the current bottom-up cost-of-illness calculations, while costs of nursing home patients were considered by official reimbursement to determine the disease burden from a societal viewpoint.
The mean age of the patients was 77.4 years (SD=9.2), 59% of them were female. The mean MMSE score was 16.70 (SD=7.24), and the mean EQ-5D score was 0.40 (SD=0.34). The average annual cost of dementia was 6,432 Euros per patient living at home and 6,086 Euros per patient living in nursing homes. For the whole demented population (based on EuroCoDe data) we estimated total annual costs of 846.8 million Euros; of which 55% are direct costs, 9% indirect costs and 36% informal care cost. Compared to acute myocardial infarction the total disease burden of dementia is 26.3 times greater.
This is the first study investigating resource utilisation, costs, and quality of life of dementia patients in the Central and Eastern European region. Compared to the general population of Hungary EQ-5D values of the demented patients are lower in all age groups. Dementia related costs are much lower in Hungary compared to Western European countries. There is no remarkable difference between the costs of demented patients living at home and in nursing homes, from the societal point of view.
本文旨在概述匈牙利的痴呆症患者的生活质量、医疗保健利用情况和成本。
2008 年,在三个家庭医生诊所和一个门诊环境中,对 88 名连续的痴呆症患者及其照顾者进行了一项基于横断面的非人群研究。调查了资源利用(RUD)、简易精神状态检查(MMSE)和生活质量(EQ-5D),并进行了成本计算。通过当前的自下而上的疾病成本计算来估算在家中生活的患者的成本,而考虑护理院患者的官方报销来从社会角度确定疾病负担。
患者的平均年龄为 77.4 岁(标准差=9.2),其中 59%为女性。平均 MMSE 得分为 16.70(标准差=7.24),平均 EQ-5D 得分为 0.40(标准差=0.34)。在家中生活的痴呆症患者的平均年费用为每位患者 6432 欧元,在护理院生活的患者的平均年费用为每位患者 6086 欧元。根据 EuroCoDe 数据,我们估计整个痴呆症患者群体的年总成本为 8.468 亿欧元;其中 55%为直接成本,9%为间接成本,36%为非正式护理成本。与急性心肌梗死相比,痴呆症的总疾病负担要大 26.3 倍。
这是首次在中东欧地区调查痴呆症患者的资源利用、成本和生活质量的研究。与匈牙利的一般人群相比,所有年龄组的痴呆症患者的 EQ-5D 值都较低。与西欧国家相比,匈牙利的痴呆症相关成本要低得多。从社会角度来看,在家中生活的痴呆症患者和在护理院生活的患者的成本没有明显差异。